Finally, we propose that silencing Mat1a in obesity activates NRF2 in hepatocytes and induces the secretion of FGF21 to the general circulation, which increases WAT lipolysis and BAT thermogenesis, decreasing de novo lipogenesis in the liver. The gene discussed is NFE2L2; the disease is obesity disorder.